Jan D. Lunemann
Jan D. Lunemann
Bestätigte E-Mail-Adresse bei uzh.ch
Zitiert von
Zitiert von
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ...
autophagy 17 (1), 1-382, 2021
Antiviral immune responses: triggers of or triggered by autoimmunity?
C Münz, JD Lünemann, MT Getts, SD Miller
Nature Reviews Immunology 9 (4), 246-258, 2009
The initiation and prevention of multiple sclerosis
A Ascherio, KL Munger, JD Lünemann
Nature Reviews Neurology 8 (11), 602-612, 2012
EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-γ and IL-2
JD Lünemann, I Jelčić, S Roberts, A Lutterotti, B Tackenberg, R Martin, ...
Journal of Experimental Medicine 205 (8), 1763-1773, 2008
TNF-related apoptosis inducing ligand (TRAIL) as a potential response marker for interferon-beta treatment in multiple sclerosis
KP Wandinger, JD Lünemann, O Wengert, J Bellmann-Strobl, O Aktas, ...
The Lancet 361 (9374), 2036-2043, 2003
Impaired inhibitory Fcγ receptor IIB expression on B cells in chronic inflammatory demyelinating polyneuropathy
B Tackenberg, I Jelčić, A Baerenwaldt, WH Oertel, N Sommer, ...
Proceedings of the National Academy of Sciences 106 (12), 4788-4792, 2009
Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis
JD Lünemann, N Edwards, PA Muraro, S Hayashi, JI Cohen, C Münz, ...
Brain 129 (6), 1493-1506, 2006
A type I interferon signature in monocytes is associated with poor response to interferon-β in multiple sclerosis
M Comabella, JD Lünemann, J Rio, A Sanchez, C Lopez, E Julia, ...
Brain 132 (12), 3353-3365, 2009
Elevated Epstein–Barr virus‐encoded nuclear antigen‐1 immune responses predict conversion to multiple sclerosis
JD Lünemann, M Tintoré, B Messmer, T Strowig, Á Rovira, H Perkal, ...
Annals of Neurology: Official Journal of the American Neurological …, 2010
Intravenous immunoglobulin in neurology—mode of action and clinical efficacy
JD Lünemann, F Nimmerjahn, MC Dalakas
Nature Reviews Neurology 11 (2), 80-89, 2015
Sialylation of IgG Fc domain impairs complement-dependent cytotoxicity
I Quast, CW Keller, MA Maurer, JP Giddens, B Tackenberg, LX Wang, ...
The Journal of clinical investigation 125 (11), 4160-4170, 2015
Viral triggers of multiple sclerosis
K Kakalacheva, C Münz, JD Lünemann
Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1812 (2), 132-140, 2011
Infectious causes of multiple sclerosis
G Giovannoni, GR Cutter, J Lunemann, R Martin, C Münz, S Sriram, ...
The Lancet Neurology 5 (10), 887-894, 2006
Death ligand TRAIL induces no apoptosis but inhibits activation of human (auto) antigen-specific T cells
JD Lünemann, S Waiczies, S Ehrlich, U Wendling, B Seeger, T Kamradt, ...
The Journal of Immunology 168 (10), 4881-4888, 2002
Regulatory NK-cell functions in inflammation and autoimmunity
A Lünemann, JD Lünemann, C Münz
Molecular medicine 15 (9), 352-358, 2009
Epstein-Barr virus: environmental trigger of multiple sclerosis?
JD Lünemann, T Kamradt, R Martin, C Münz
Journal of virology 81 (13), 6777-6784, 2007
β‐Amyloid is a substrate of autophagy in sporadic inclusion body myositis
JD Lünemann, J Schmidt, D Schmid, K Barthel, A Wrede, MC Dalakas, ...
Annals of Neurology: Official Journal of the American Neurological …, 2007
Environmental triggers of multiple sclerosis
K Kakalacheva, JD Lünemann
FEBS letters 585 (23), 3724-3729, 2011
TNF-α induces macroautophagy and regulates MHC class II expression in human skeletal muscle cells
CW Keller, C Fokken, SG Turville, A Lünemann, J Schmidt, C Münz, ...
Journal of Biological Chemistry 286 (5), 3970-3980, 2011
Fc-galactosylation of human immunoglobulin gamma isotypes improves C1q binding and enhances complement-dependent cytotoxicity
B Peschke, CW Keller, P Weber, I Quast, JD Lünemann
Frontiers in immunology 8, 646, 2017
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20